In humans, the gut microbiota forms a complex ecosystem consisting of a vast number of bacteria, Archaea, fungi and viruses. It represents a major stimulus to the development of the immune system and many other physiological functions, so that it may shape the individual's susceptibility to infectious and immune-mediated diseases. The emergence of new '-omics' methods recently revolutionized the way we study the host-microbe interactions, but they also raised new questions and issues. In this review, we discuss the impact of these new data on the current and future therapies for chronic inflammatory diseases. We also outline the major conceptual, technical and interpretational issues that recently led to some misleading conclusions and discuss in brief the current research directions in the field.

Institute of Microbiology The Czech Academy of Sciences Prague Czech Republic

Citace poskytuje Crossref.org

Associations Among Estrogens, the Gut Microbiome and Osteoporosis

Microbiota as the unifying factor behind the hallmarks of cancer

Contribution of Infectious Agents to the Development of Celiac Disease

Monoassociation of Preterm Germ-Free Piglets with Bifidobacterium animalis Subsp. lactis BB-12 and Its Impact on Infection with Salmonella Typhimurium

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917

Update on Menopausal Hormone Therapy for Fracture Prevention

Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response

Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis